Genesco (GCO) Asset Writedowns and Impairment (2010 - 2026)

Genesco's Asset Writedowns and Impairment history runs 17 years deep, the most recent figure standing at $478000.0 for Q1 2026.

• On a quarterly basis, Asset Writedowns and Impairment fell 46.29% year-over-year to $478000.0 in Q1 2026; TTM through May 2026 was $4.3 million, a 269.68% increase from a year earlier, with the FY2026 full-year figure at $4.4 million, up 216.04% from the prior year.
• Asset Writedowns and Impairment retreated to $478000.0 in Q1 2026 per GCO's latest filing, from $3.9 million in the prior quarter.
• Across five years, Asset Writedowns and Impairment topped out at $3.9 million in Q4 2025 and bottomed at $34000.0 in Q2 2025.
• The 5-year median for Asset Writedowns and Impairment is $276000.0 (2023), against an average of $590428.6.
• Across the five-year window, Asset Writedowns and Impairment plunged 90.85% in 2022 and soared 2782.09% in 2025, its largest moves.
• Year by year, Asset Writedowns and Impairment stood at $129000.0 in 2022, then declined by 23.26% to $99000.0 in 2023, then jumped by 35.35% to $134000.0 in 2024, then surged by 2782.09% to $3.9 million in 2025, then plunged by 87.62% to $478000.0 in 2026.
• Per Business Quant, the three latest GCO Asset Writedowns and Impairment figures stand at $478000.0 (Q1 2026), $3.9 million (Q4 2025), and $34000.0 (Q2 2025).